Industry Update: Biotechnology
VRC is proud to release its latest industry report. The report provides a concise, insightful update on the Biotechnology industry including recent transactions, market multiples, company performance and purchase price allocation percentages.
I
ndustry Highlights
- On September 25, 2023, Regeneron Pharmaceuticals, Inc. announced that it
successfully completed its $209 million acquisition of Decibel Therapeutics, Inc. The acquisition of Decibel builds on prior collaboration between the companies and includes three ongoing gene therapy programs targeting different forms of congenital, monogenic hearing loss. - On August 10, 2023, Novo Nordisk announced that it agreed to acquire Inversago for up to $1.075 billion in cash if certain development and commercial milestones are achieved. Inversago Pharma is a private, Montreal-based developer of CB1 receptor-based therapies for the potential treatment of obesity, diabetes and complications associated with metabolic disorders.
